Ben Palleiko, KalVista Pharmaceuticals CEO

KalVista CEO says FDA re­view pro­ceed­ed nor­mal­ly, was un­aware of Makary's re­jec­tion ask

The CEO of KalVista Phar­ma­ceu­ti­cals de­scribed the be­hind-the-scenes dis­cus­sions with FDA re­view­ers as “ap­pro­pri­ate,” “thor­ough” and “pro­duc­tive” in what led to

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.